CAG
DNA icon

Crestwood Advisors Group’s Ginkgo Bioworks DNA Stock Holding History

Crestwood Advisors Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-924
Closed -$12.4K – 445
2024
Q2 		$12.4K Hold
924
– – ﹤0.01% 424
2024
Q1 		$42.9K Hold
924
– – ﹤0.01% 414
2023
Q4 		$62.5K Hold
924
– – ﹤0.01% 401
2023
Q3 		$66.9K Buy
924
+500
+118% +$40K ﹤0.01% 358
2023
Q2 		$31.6K Sell
424
-38
-8% -$2.25K ﹤0.01% 254
2023
Q1 		$24.6K Hold
462
– – ﹤0.01% 258
2022
Q4 		$31.2K Hold
462
– – ﹤0.01% 260
2022
Q3 		$58K Hold
462
– – ﹤0.01% 259
2022
Q2 		$44K Hold
462
– – ﹤0.01% 261
2022
Q1 		$74K Buy
+462
New +$89.9K ﹤0.01% 280

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return